ZIRABEV conc perf 400 mg/16ml vial 16 ml
7680675010028
CH-67501
L01FG01
07.16.1.
Reimbursement limitations:
ZIRABEV.01
Carcinome colorectal
Après accord sur la prise en charge des frais par l’assureur-maladie après consultation …
1 / 3
google
Details
- Product number
- 6750102
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- bevacizumabum 400 mg, acidum succinicum, saccharum, dinatrii edetas, polysorbatum 80, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 16 ml corresp. natrium 9.29 mg.
Articles (1)
Zirabev 400 mg/16 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
400.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
9.29 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 1063.55
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/08/2020
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 67501
- Drug name
- Zirabev, Konzentrat zur Herstellung einer lnfusionslösung
- Galenic form
- KOINF
- ATC Code
- L01FG01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 10/05/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ZIRABEV conc perf 400 mg/16ml vial 16 ml
- Description (DE)
- ZIRABEV Inf Konz 400 mg/16ml Vial 16 ml
- Market launch
- 10/05/2020
- Narcotic (BTM)
- No